• Skip to main content

Aphios

Inspired by Nature, Enabled by Science®

  • Products
    ▼
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      ▼
      • Oncology
        ▼
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        ▼
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          ▼
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        ▼
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        ▼
        • APH-0907
    • Research Chemicals & APIs
      ▼
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    ▼
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      ▼
      • CFN
      • PNS
      • PNP
    • Drug Safety
      ▼
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      ▼
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      ▼
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    ▼
    • Investors Overview
      ▼
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    ▼
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop
  • Products
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      • Oncology
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        • APH-0907
    • Research Chemicals & APIs
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      • CFN
      • PNS
      • PNP
    • Drug Safety
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    • Investors Overview
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop

Press Releases

← Back to Press Releases

Aphios Awarded NIH SBIR Grant For Development of Anti-CCR5 Nanoparticles to Treat Alzheimer’s Disease

North Reading, Mass. – December 11, 2024 − Aphios announced today that it was awarded an NIH SBIR grant from the National Institute on Aging (NIA) to develop anti-CCR5 nanoparticles to treat Alzheimer’s disease.

Alzheimer’s disease and dementia are debilitating diseases affecting over 6.7 million people in the United States and over 55 million people worldwide. Alzheimer’s disease has been characterized by multiple factors, including but not limited to amyloid plaque formation, tau protein entanglement, enzyme degradation and inflammation. Inflammation in the brain is associated with the CCR5 gene that increases with age. CCR5 has been correlated with impairments in memory consolidation in aged mice, which was reversed with a CCR5 knockout drug that inhibits this receptor.

According to Dr. Trevor P. Castor, Principal Investigator, “We are utilizing targeted nanoparticles manufactured by our proprietary PNS (polymer nanoparticles) technology to transport the anti- CCR5 antagonist across the blood brain barrier (BBB) to knock down the CCR5 gene, control inflammation, and manage dementia and Alzheimer’s disease.” Additionally, he continues, “Our nanotechnology platform will be able to co-transport our anti-CCR5 antagonist with other therapeutics such as anti-amyloid antibodies with different and potentially synergistic mechanisms of actions into the Alzheimer’s disease brain.”

About Aphios Corporation: 

Aphios Corporation is a clinical stage biotechnology company developing enabling technology platforms to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic safety of biologics. Based on these platforms, we are developing enhanced therapeutics to prevent disease, maintain health/improve quality-of-life and treat chronic diseases including cancers/supportive care, infectious diseases such as HIV/AIDS, influenza and COVID-19, and CNS disorders such as Alzheimer’s disease in an environmentally sustainable manner.

Research reported in this press release is supported by the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Number R43AG085863. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Aphios

Inspired by Nature, Enabled by Science®

© 2026 Aphios Corporation

Contact Us

  • [email protected]
  • (781) 932-6933
  • 87 Main Street, North Reading, MA 01864 USA
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram
  • Tik Tok